US Edition
Insider Buying: Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) CEO Purchases 20,000 Shares of Stock
Summary by tickerreport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Insider Buying: Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) CEO Purchases 20,000 Shares of Stock
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) CEO Mihael Hristos Polymeropoulos purchased 20,000 shares of the business’s stock in a transaction on Friday, May 16th. The stock was purchased at an average cost of $4.22 per share, for a total transaction of $84,400.00. Following the completion of the acquisition, the chief executive officer now […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
